about
Hemoglobinopathies: slicing the Gordian knot of Plasmodium falciparum malaria pathogenesisDietary strategies for improving iron status: balancing safety and efficacy.Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of hepatocytesKetamine does not produce relief of neuropathic pain in mice lacking the β-common receptor (CD131).Influence of host iron status on Plasmodium falciparum infection.RBC barcoding allows for the study of erythrocyte population dynamics and P. falciparum merozoite invasionThe basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of Plasmodium falciparum sporozoites.In vitro and in vivo antimalarial activity of amphiphilic naphthothiazolium salts with amine-bearing side chains.Host iron status and iron supplementation mediate susceptibility to erythrocytic stage Plasmodium falciparumAsialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo.A double blind randomised controlled trial comparing standard dose of iron supplementation for pregnant women with two screen-and-treat approaches using hepcidin as a biomarker for ready and safe to receive iron.Efficacy and safety of hepcidin-based screen-and-treat approaches using two different doses versus a standard universal approach of iron supplementation in young children in rural Gambia: a double-blind randomised controlled trial.Oral iron acutely elevates bacterial growth in human serum.Rapid clearance of malaria circumsporozoite protein (CS) by hepatocytes.Anemia Offers Stronger Protection Than Sickle Cell Trait Against the Erythrocytic Stage of Falciparum Malaria and This Protection Is Reversed by Iron SupplementationThe role of the red blood cell in host defence against falciparum malaria: an expanding repertoire of evolutionary alterations.Structural and functional properties of region II-plus of the malaria circumsporozoite proteinHost iron status and erythropoietic response to iron supplementation determines susceptibility to the RBC stage of falciparum malaria during pregnancy.Iron fortification and malaria risk in children.Binding of malarial circumsporozoite protein to sulfatides [Gal(3-SO4)beta 1-Cer] and cholesterol-3-sulfate and its dependence on disulfide bond formation between cysteines in region II.Iron Nutriture of the Fetus, Neonate, Infant, and Child.Biopreservation of RBCs for in vitro Plasmodium falciparum culture.African women working in global health: closing the gender gap in Africa?High-performance liquid chromatographic method for guanylhydrazone compoundsRespiratory infections drive hepcidin-mediated blockade of iron absorption leading to iron deficiency anemia in African childrenGuts, Germs, and Iron: A Systematic Review on Iron Supplementation, Iron Fortification, and Diarrhea in Children Aged 4-59 MonthsThe ferroportin Q248H mutation protects from anemia, but not malaria or bacteremiaNeonatal iron distribution and infection susceptibility in full term, preterm and low birthweight babies in urban Gambia: study protocol for an observational studyHepcidin mediates hypoferremia and reduces the growth potential of bacteria in the immediate post-natal period in human neonates
P50
Q24810377-F2E99317-E1DD-46AD-8D92-853E27BD7F83Q28817448-97671D75-3350-43FC-9D3A-2480A14852D6Q30039117-9D9F7D35-D999-4C32-B27B-FD9560870386Q31126222-8A95FB84-B5AB-484B-8BD6-2789C95F9F44Q33600477-4C5C1501-74AD-4713-8726-D4E106485D7BQ33830833-FDC784B1-C633-4004-BE0E-248B65236435Q34237481-7D9DE964-EF8E-4795-B525-1493A4A16335Q34281672-2D1245C7-9D3E-4E86-A7F4-AA5F4DF776E4Q34598503-7A77D061-16FC-4BFA-929A-0DC9DD17571EQ35144156-1EC3402D-2407-4957-896B-D9CE322FD7DAQ36076441-287B409F-6AD2-48F1-AAFE-AF5C6133FA83Q36120413-63477C3F-A781-49C1-AD34-4BE3CA1C0A70Q36305688-90634FD3-4156-4B6F-8EE1-51605D3FA7F5Q36362740-5D080154-458E-435F-9452-F1B635E402D2Q37510176-095ACC54-B37B-4DBA-864E-05ECAF8E36D0Q39026326-0A21114C-F1D3-425A-A9DE-E9A7F0E671FDQ41811030-56C4FACF-CD5E-4840-99F5-F001653200A7Q46947890-5051B6F1-5A9E-4345-8493-2B86225545EEQ47835970-C8800541-3FBB-4F5A-B263-B441028B93BCQ47858403-3041B5E5-A090-4B3E-AEAE-99BC4ACA13B5Q47901328-91E45209-BC38-4F1B-9EB4-AB078DCA998EQ47943734-E053AF5E-7DD3-4378-8673-5712E8A9E9F9Q59402046-A8AA0956-E4D0-47B8-9D25-039BFA399DE9Q59403282-D0CF5424-A690-4D13-9C05-A5A3634D0548Q63692891-C14B445A-34AD-4338-855F-A27D4A53A220Q64263677-E52DBD21-DD51-47C4-B87F-ECE4D72755C1Q90089158-2F5A0FE3-6C8D-4D0D-AD60-963CD2B33007Q90538000-0FE6984C-2F3A-468F-BDE5-D82C35681E6FQ91260324-B0DA05D4-F494-4639-9288-4EAA57134CCA
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
C Cerami
@ast
C Cerami
@en
C Cerami
@es
C Cerami
@nl
C Cerami
@sl
type
label
C Cerami
@ast
C Cerami
@en
C Cerami
@es
C Cerami
@nl
C Cerami
@sl
prefLabel
C Cerami
@ast
C Cerami
@en
C Cerami
@es
C Cerami
@nl
C Cerami
@sl
P106
P1153
6507924549
P31
P496
0000-0002-7634-0955